DK112888A - Aktiveret rnase l som markoer for virusinfektioner - Google Patents

Aktiveret rnase l som markoer for virusinfektioner

Info

Publication number
DK112888A
DK112888A DK112888A DK112888A DK112888A DK 112888 A DK112888 A DK 112888A DK 112888 A DK112888 A DK 112888A DK 112888 A DK112888 A DK 112888A DK 112888 A DK112888 A DK 112888A
Authority
DK
Denmark
Prior art keywords
pathway
rnase
aids
biochemical
inhibitor
Prior art date
Application number
DK112888A
Other languages
Danish (da)
English (en)
Other versions
DK112888D0 (da
Inventor
William A Carter
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of DK112888D0 publication Critical patent/DK112888D0/da
Publication of DK112888A publication Critical patent/DK112888A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • G01N2333/922—Ribonucleases (RNAses); Deoxyribonucleases (DNAses)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK112888A 1987-03-03 1988-03-02 Aktiveret rnase l som markoer for virusinfektioner DK112888A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2137287A 1987-03-03 1987-03-03

Publications (2)

Publication Number Publication Date
DK112888D0 DK112888D0 (da) 1988-03-02
DK112888A true DK112888A (da) 1988-09-04

Family

ID=21803819

Family Applications (1)

Application Number Title Priority Date Filing Date
DK112888A DK112888A (da) 1987-03-03 1988-03-02 Aktiveret rnase l som markoer for virusinfektioner

Country Status (20)

Country Link
EP (1) EP0285263B1 (fr)
JP (1) JPH0675520B2 (fr)
KR (1) KR880011593A (fr)
AT (1) ATE107964T1 (fr)
AU (1) AU618525B2 (fr)
CA (1) CA1337278C (fr)
DE (1) DE3850428T2 (fr)
DK (1) DK112888A (fr)
ES (1) ES2058252T3 (fr)
FI (1) FI880959A7 (fr)
IE (1) IE66831B1 (fr)
IL (1) IL85576A0 (fr)
MX (1) MX173802B (fr)
NO (1) NO880934L (fr)
NZ (1) NZ223721A (fr)
OA (1) OA08720A (fr)
PH (1) PH30882A (fr)
PT (1) PT86878B (fr)
RU (1) RU2049336C1 (fr)
ZA (1) ZA881471B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0306347B1 (fr) * 1987-09-04 1995-05-10 Hem Pharmaceuticals Corp. Diagnostic des déficiences en RNA double-brin
US5593973A (en) * 1987-09-04 1997-01-14 Hemispherx Biopharma Inc. Treatment of viral hepatitis with mismatched dsRNA
AU724056B2 (en) * 1987-09-04 2000-09-14 Hem Research, Inc. Diagnosis and treatment of double stranded deficiency states
DE68914201T2 (de) * 1988-07-07 1994-07-14 Hem Pharma Corp Diagnose und Behandlung chronischer Ermüdungserscheinungen.
US5985565A (en) * 1996-10-09 1999-11-16 Temple University-Of The Commonwealth System Of Higher Education Chronic fatigue syndrome diagnosis
US6207366B1 (en) 1999-04-14 2001-03-27 Temple University- Of The Commonwealth System Of Higher Education Chronic fatigue syndrome diagnosis
US6080554A (en) * 1999-04-27 2000-06-27 R.E.D. Laboratories, N.V. Methods and compositions for use in characterizing multiple sclerosis disease activity in a subject
RU2202110C1 (ru) * 2001-07-26 2003-04-10 Научно-исследовательский испытательный центр (медико-биологической защиты) Государственного научно-исследовательского испытательного института военной медицины МО РФ Способ определения активности и функционального состояния синтетазы оксида азота
WO2017193051A1 (fr) * 2016-05-06 2017-11-09 The Trustees Of Princeton University Procédés de surveillance de l'activité de rnase l

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0113162B1 (fr) * 1982-09-16 1989-07-19 Hem Research, Inc. Effet antinéoplastiques des acides ds-ribonucléiques sur les cellules des tumeurs
CA1326450C (fr) * 1985-08-26 1994-01-25 William A. Carter Modulation des manifestations associees au virus du sida au moyen d'arn a double brin

Also Published As

Publication number Publication date
OA08720A (en) 1989-03-31
PT86878B (pt) 1992-05-29
IE880587L (en) 1988-09-03
FI880959A0 (fi) 1988-03-02
ZA881471B (en) 1988-12-28
DE3850428T2 (de) 1994-11-24
IL85576A0 (en) 1988-08-31
AU1256388A (en) 1988-09-01
FI880959A7 (fi) 1988-09-04
KR880011593A (ko) 1988-10-29
MX173802B (es) 1994-03-29
DE3850428D1 (de) 1994-08-04
JPH0675520B2 (ja) 1994-09-28
RU2049336C1 (ru) 1995-11-27
JPS63309200A (ja) 1988-12-16
PT86878A (pt) 1988-04-01
NO880934L (no) 1988-09-05
NO880934D0 (no) 1988-03-02
AU618525B2 (en) 1992-01-02
EP0285263B1 (fr) 1994-06-29
CA1337278C (fr) 1995-10-10
ES2058252T3 (es) 1994-11-01
DK112888D0 (da) 1988-03-02
IE66831B1 (en) 1996-02-07
PH30882A (en) 1997-12-23
EP0285263A2 (fr) 1988-10-05
ATE107964T1 (de) 1994-07-15
EP0285263A3 (en) 1990-04-18
NZ223721A (en) 1991-02-26

Similar Documents

Publication Publication Date Title
DK112888D0 (da) Aktiveret rnase l som markoer for virusinfektioner
MY138860A (en) Hiv protease inhibitors.
WO1994023041A3 (fr) Procede d'inactivation selective de replication virale
ES512148A0 (es) "una estructura de manipulador robotico, por ejemplo para el montaje de componentes de poco peso."
WO2003079757A3 (fr) Therapeutique du vih
TR199901530T2 (xx) HIV ve kanser tedavisi.
DK0973735T3 (da) Polyaromatiske antivirale præparater
FI883763A0 (fi) Frigoering av vaerdens foersvarsmediatorer i biologiska vaetskor genom systematisk behandling med dubbelstraengat rna.
BR0005799A (pt) Sistema hidráulico
DE69320945D1 (de) Antivirale nukleosidanaloge
SE8601435D0 (sv) Aktivt pansar
SE8601295D0 (sv) Bojbar balk, serskilt avsedd for anvendning som stotfangare vid fordon
ATE130760T1 (de) Synergistische wechselwirkung von interleukin-2 und doppelsträngiger rns.
ES2195370T3 (es) Procedimiento para la preparacion de 2`-fluoro-5-metil-beta-l-arabinofuranosiluridina.
GB2011041A (en) Practice or Fragmentation Projectiles
ATE178335T1 (de) Therapeutische nukleoside der 2',3'-dideoxy-3'- fluor -purin reihe
DK0734380T3 (da) 4-Benzoylisoxazoler samt deres anvendelse som herbicider
DE69718911D1 (de) Interleukin - 8 als antivirale- und antitumorwirkstoffe
ES8303680A1 (es) "perfeccionamientos en la fabricacion de proyectiles con accionamiento pirotecnico".
GB0016020D0 (en) New polyciclic xanthones and their use
AR247215A1 (es) Un procedimiento para producir un antibiotico antifungico y antiviral, n-acetilbenanomicina b.
NO960849L (no) Difluorstaton-antivirale analoger
SU968413A1 (ru) Раствор дл ослаблени горных пород
AU1979283A (en) Nitroglycerine solution
IT1244893B (it) Utensile universale per sistema di tornitura esterna.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment